International Conference on Clinical Pharmacology, Pharmacy and Hemotherapy
ICCPPH
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest innovations in bio-pharmaceutics and pharmaceutics, focusing on formulation strategies and their implications for drug delivery. Researchers are invited to present findings on novel drug formulations and their therapeutic applications.
SDG 3
SDG 9
This session will address the critical role of pharmacy practice in enhancing patient safety and minimizing adverse drug effects. Discussions will include best practices, case studies, and strategies for effective medication management.
SDG 3
SDG 4
This track will delve into the chemical aspects of drug development, including synthesis, characterization, and optimization of pharmaceutical compounds. Participants are encouraged to share their research on innovative chemical methodologies and their impact on drug efficacy.
SDG 3
SDG 9
This session will focus on the pharmacological mechanisms of antibiotics and anti-neoplastic drugs, emphasizing their clinical applications and resistance patterns. Contributions on novel therapeutic approaches and combination therapies are particularly welcome.
SDG 3
SDG 4
This track will examine the integration of clinical pharmacology with personalized medicine, highlighting the importance of tailoring drug therapies to individual patient profiles. Presentations will cover pharmacogenetics, pharmacogenomics, and their implications for treatment outcomes.
SDG 3
SDG 9
This session will focus on the processes of drug metabolism and pharmacokinetics, exploring how these factors influence drug efficacy and safety. Researchers are invited to discuss their findings on drug interactions and the role of drug-metabolizing enzymes.
SDG 3
SDG 4
This track will highlight recent advancements in hematology and laboratory medicine, including diagnostic techniques and therapeutic interventions. Participants are encouraged to present research that bridges laboratory findings with clinical applications.
SDG 3
SDG 4
This session will cover the entire spectrum of drug discovery, from target identification and validation to preclinical and clinical trial methodologies. Contributions on innovative approaches to drug design and development are highly encouraged.
SDG 3
SDG 9
This track will explore the role of pharmacogenetics in optimizing drug therapy and improving patient outcomes. Discussions will include genetic variations that affect drug response and strategies for implementing pharmacogenetic testing in clinical practice.
SDG 3
SDG 4
This session will focus on rapid methods for assessing the quality and stability of bio-therapeutics, emphasizing the importance of rigorous testing in ensuring therapeutic efficacy. Researchers are invited to share innovative approaches and technologies in this field.
SDG 3
SDG 4
This track will examine the evolving role of nursing pharmacology in patient care, focusing on the integration of pharmacological knowledge into nursing practice. Presentations will cover education, clinical guidelines, and the impact of nursing interventions on medication management.
SDG 3
SDG 4